International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Clinical trial NCT07476729 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07476729
Sponsor: Charite University, Berlin, Germany
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

B-Cell Acute Lymphoblastic Leukaemia

Start date: 2026-04-01
Primary completion: 2033-03-31
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.